Identification |
Name: | Cyclohepta[b]pyrazolo[3,4-d]pyridin-3(2H)-one,5,6,7,8,9,10-hexahydro-2-(4-methoxyphenyl)- |
Synonyms: | 5,6,7,8,9,10-Hexahydro-2-(p-methoxyphenyl)cyclohepta[b]pyrazolo[3,4-d]pyridin-3(2H)-one;CGS 20625 |
CAS: | 111205-55-1 |
Molecular Formula: | C18H19 N3 O2 |
Molecular Weight: | 309.36236 |
InChI: | InChI=1/C18H19N3O2/c1-23-13-9-7-12(8-10-13)21-18(22)15-11-19-16-6-4-2-3-5-14(16)17(15)20-21/h7-11,20H,2-6H2,1H3 |
Molecular Structure: |
|
Properties |
Flash Point: | 258.5°C |
Boiling Point: | 503.8°Cat760mmHg |
Density: | 1.246g/cm3 |
Refractive index: | 1.617 |
Biological Activity: | Selective, partial agonist for the benzodiazepine binding site of the GABA A receptor. Potently inhibits [3H]-flunitrazepam binding to central benzodiazepine receptors (IC 50 = 1.3 nM) and displays weak affinity for peripheral benzodiazepine (IC 50 = 0.68 - 2.25 μ M) and GABA binding sites (IC 50 > 10000 μ M). Displays anxiolytic activity in vivo following oral administration. |
Flash Point: | 258.5°C |
Safety Data |
|
|